Investor Presentaiton slide image

Investor Presentaiton

Innovation and therapeutic focus Do + R&D investor presentation Further raise the innovation bar for diabetes treatment • Develop a leading portfolio of superior treatment solutions for obesity • • Strengthen and progress the Biopharm pipeline Establish presence in other serious chronic diseases focusing on CVD, NASH and CKD CVD: Cardiovascular disease; NASH: Non-alcoholic steatohepatitis; CKD: Chronic kidney disease. Marcus Schindler SVP Global Drug Discovery
View entire presentation